Demonstrating Evidence of Acceptability: The “Catch‐22” of Pediatric Formulation Development

E-ISSN： 1532-6535|94|5|582-584

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.94, Iss.5, 2013-11, pp. : 582-584

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A catch‐22: Interleukin‐22 and cancer

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 48, Iss. 1, 2018-01 ,pp. : 15-31

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development of Pediatric Neurosurgery

Pediatric Neurosurgery, Vol. 32, Iss. 2, 2000-05 ,pp. : 57-57

Karger

Access to resources Recommend Favorite

Subcutaneous panniculitis‐like T‐cell lymphoma: Pediatric case series demonstrating heterogeneous presentation and option for watchful waiting

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 11, 2015-11 ,pp. : 2025-2028

John Wiley & Sons Inc

Access to resources Recommend Favorite

Subcutaneous panniculitis‐like T‐cell lymphoma: Pediatric case series demonstrating heterogeneous presentation and option for watchful waiting

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 1545-5009, Iss. 11, 2015-11 ,pp. : 2025-2028

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatitis B Virus Immunization Before and After Pediatric Liver Transplantation: Check, Catch‐Up, and Check Again!

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 8, 2015-08 ,pp. : 2275-2276

John Wiley & Sons Inc

Access to resources Recommend Favorite